Yuki Gosei Kogyo Co., Ltd. stock analysis
Want to see JP:4531 full AI Analyst Report?
Yuki Gosei Kogyo Co., Ltd. (4531) Stock Price & Analysis
4531 Stock Chart & Stats
- Day’s Range
- JPY 311.00 - JPY 320.00
- 52-Week Range
- JPY 278.00 - JPY 640.00
- Previous Close
- JPY 332.00
- Volume
- N/A
- Average Volume (3M)
- 49.05K
- Market Cap
- JPY 6.90B
- Enterprise Value
- JPY 11.67B
- Total Cash (Recent Filing)
- JPY 1.39B
- Total Debt (Recent Filing)
- JPY 6.36B
- Price to Earnings (P/E)
- 14.8
- Beta
- 1.26
- Next Earnings
- Jan 29, 2027 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- Mar 30, 2027
- Dividend Yield
- 3.16%
Bulls Say, Bears Say
Bulls Say
Solid Equity Base
An equity base that consistently exceeds total debt provides a meaningful financial cushion and reduces balance-sheet fragility. This supports resilience through operating volatility and preserves flexibility to fund investment or manage obligations over the next several quarters.
2026 Cash Flow Rebound
The strong 2026 operating and free cash flow rebound shows that the business generated substantial internal cash in the latest year. If maintained, this can support investment, debt management, and shareholder returns without relying as heavily on external financing.
Earlier Profitability Improvement
The multi-year improvement through 2025 indicates that the company had been expanding revenue and strengthening profitability before the latest setback. That prior progress provides an established earnings base and suggests the business has demonstrated an ability to improve operating performance over time.
Bears Say
2026 Earnings Decline
The 2026 revenue contraction and sharp net income decline represent a material reversal from the prior improvement trend. Persistent weakness would reduce earnings power, constrain reinvestment capacity, and make future profitability more dependent on recovering demand or controlling costs.
Inconsistent Free Cash Flow
Negative free cash flow across three consecutive years shows that internal cash generation was not consistently sufficient to fund investment needs. Although 2026 improved materially, the earlier volatility lowers confidence that the latest cash rebound will persist through the next business cycle.
Elevated Debt
Higher debt increases the financial claims that must be serviced while earnings are under pressure. Even with equity above debt and moderate leverage, the combination of elevated borrowings and weaker 2026 profitability could reduce flexibility for investment and capital allocation.
Yuki Gosei Kogyo Co., Ltd. News
4531 FAQ
What was Yuki Gosei Kogyo Co., Ltd.’s price range in the past 12 months?
What is Yuki Gosei Kogyo Co., Ltd.’s market cap?
When is Yuki Gosei Kogyo Co., Ltd.’s upcoming earnings report date?
How were Yuki Gosei Kogyo Co., Ltd.’s earnings last quarter?
Is Yuki Gosei Kogyo Co., Ltd. overvalued?
Does Yuki Gosei Kogyo Co., Ltd. pay dividends?
What is Yuki Gosei Kogyo Co., Ltd.’s EPS estimate?
How many shares outstanding does Yuki Gosei Kogyo Co., Ltd. have?
What happened to Yuki Gosei Kogyo Co., Ltd.’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Yuki Gosei Kogyo Co., Ltd.?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Yuki Gosei Kogyo Co., Ltd.
Yuki Gosei Kogyo Co., Ltd. is a Japanese enterprise that globally researches, develops, produces, and markets sophisticated fine chemical products. Their diverse portfolio encompasses food-grade additives, pharmaceutical components, and chemicals for industrial and agricultural applications. Key offerings include glycine and its derivatives, nicotinamide, isoniazid, various drug intermediates, and cosmetic raw materials. The company also provides a range of specialized compounds, such as those based on amino acids, pyridine, piperidine, and silicon, alongside biological products like DNA, nucleosides, protamine, and active pharmaceutical ingredients (APIs). Furthermore, they offer contract manufacturing services for pharmaceutical and chemical products. Established in 1947, Yuki Gosei Kogyo Co., Ltd. is headquartered in Tokyo, Japan.
- Sector
- General
- Industry
- Chemicals - Specialty
- CEO
- Seiichiro Matsumoto
- Employees
- 296
- Website
- www.yuki-gosei.co.jp
- Address
- 10-4, Nihonbashi-Ningyocho 3-chome, Tokyo, TY, 103-0013, JP
Yuki Gosei Kogyo Co., Ltd. (4531) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 6 | 2 | 14 |
| Technical Analysis | 6 | 2 | 2 |
| Moving Averages | 0 | 0 | 12 |








